weight regain after stopping glp-1 agonists Patients rapidly weight loss drugs – but still keep off a quarter of weight lost New research from @doctorsigh shows

Description

[DOI] [PubMed] [Google Scholar] 81.Daniele G., Iozzo P., Molina-Carrion M., Lancaster J., Ciociaro D., Cersosimo E

While numerous other GLP1 receptor agonists have since been developed for the management of diabetes, it wasnt until 2014 that a GLP1 receptor agonist, Saxenda (liraglutide), was approved for obesity (liraglutide had previously been approved for diabetes under the name Victoza)

Balangta tip 2 diyabet tedavisi iin gelitirilen GLP-1 ilalar, zamanla diyabet d baz durumlarda da deerlendirilmitir

Liraglutide treatment in this model has alleviated cardiometabolic dysregulation and enhanced cardiac function, resulting in reduced cardiac hypertrophy and fibrosis, as well as diminished atrial weight, natriuretic peptide levels, and lung congestion [84]